Keyphrases
Idiopathic Parkinson's Disease
100%
Disease Groups
100%
Parkinson's Disease
83%
Pathogenic Variants
50%
Leucine-rich Repeat Kinase 2 (LRRK2)
50%
Clinical Data
50%
VPS35
50%
Genetic Data
33%
DJ-1
33%
International Cohort
33%
Movement Disorders
16%
Movement Disorder Society
16%
Parkinson's Disorder
16%
Number of Subjects
16%
Risk Variant
16%
Gene Targeting
16%
Online Survey
16%
Pathogenicity
16%
Clinical Trials
16%
Individual-level Data
16%
Trial-ready Cohort
16%
Clinical Characterization
16%
Estimated numbers
16%
Genotype-phenotype
16%
Gene-targeted Therapy
16%
Countries Worldwide
16%
Demographic Data
16%
Quality Check
16%
Clinical Stratification
16%
Characterization Data
16%
Small Fraction
16%
Genetic Stratification
16%
Targeted Clinical Trials
16%
Biochemistry, Genetics and Molecular Biology
Genetics
100%
LRRK2
42%
VPS35
42%
PINK1
42%
Clinical Trial
28%
Medicine and Dentistry
Parkinson's Disease
100%
Clinical Trial
22%
Stereotypic Movement Disorder
22%
Diagnosis of Parkinson's Disease
11%
Pathogenicity
11%
Targeted Therapy
11%
Genetics of Parkinson's Disease
11%
Pharmacology, Toxicology and Pharmaceutical Science
Parkinson's Disease
100%
Clinical Trial
18%
Motor Dysfunction
18%
Pathogenicity
9%
Neuroscience
Parkinson's Disease
100%
Stereotypic Movement Disorder
22%
Diagnosis of Parkinson's Disease
11%
Genetics of Parkinson's Disease
11%